pristanic acid has been researched along with Chondrodysplasia Punctata in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jakobs, C; Kneer, J; Kok, RM; Poll-The, BT; Saudubray, JM; Schor, DS; Stellaard, F; ten Brink, HJ | 1 |
| Johnson, D; Poulos, A; Singh, H; Usher, S | 1 |
| Fellenberg, AJ; Johnson, DW; Poulos, A; Sharp, P | 1 |
3 other study(ies) available for pristanic acid and Chondrodysplasia Punctata
| Article | Year |
|---|---|
In vivo study of phytanic acid alpha-oxidation in classic Refsum's disease and chondrodysplasia punctata.
Topics: Administration, Oral; Adult; Carbon Dioxide; Chondrodysplasia Punctata; Fatty Acids; Humans; Infant; Male; Oxidation-Reduction; Phytanic Acid; Refsum Disease | 1992 |
Metabolism of branched chain fatty acids in peroxisomal disorders.
Topics: Adrenoleukodystrophy; Cells, Cultured; Chondrodysplasia Punctata; Fatty Acids; Fibroblasts; Heptanoic Acids; Humans; Metabolism, Inborn Errors; Microbodies; Oxidation-Reduction; Refsum Disease; Stearic Acids; Zellweger Syndrome | 1990 |
Accumulation of pristanic acid (2, 6, 10, 14 tetramethylpentadecanoic acid) in the plasma of patients with generalised peroxisomal dysfunction.
Topics: Adrenoleukodystrophy; Chondrodysplasia Punctata; Fatty Acids; Humans; Lipidoses; Microbodies; Phytanic Acid; Refsum Disease | 1988 |